Radioiodine therapy for papillary and follicular thyroid carcinoma

被引：34
|
作者：
Klain, M
Ricard, M
Leboulleux, S
Baudin, E
Schlumberger, M
机构：
[1] Inst Gustave Roussy, Dept Nucl Med, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CEA LRC 29V, F-94805 Villejuif, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2002年 / 29卷 / Suppl 2期
关键词：
radioiodine; ablation; metastases; thyroid carcinoma;
D O I：
10.1007/s00259-002-0810-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Radioiodine (I-131) therapy is used in patients with papillary and follicular thyroid carcinoma for ablation of thyroid remnants and for treatment of persistent or recurrent disease. It should be used selectively, i.e. only in those patients for whom a clinical benefit may be expected.
引用
收藏
页码：S479 / S485
页数：7
相关论文
共 50 条
12345